← all vendors
QUMAS
AI score: 54 / 100
Not generally recommended for SMB
Enterprise QMS for pharma and life sciences (Honeywell/SPARTA Systems)
Type: large / corporate · Tech: modern · Budget: enterprise ($350k+)
Core verticals: medical / bioscience, plastics / chemicals / batch
Functions: quality, reporting / BI
QUMAS was a leading quality and regulatory information management system for pharmaceutical and biotech companies. QUMAS was acquired by SPARTA Systems, which was subsequently acquired by Honeywell. The QUMAS product line has been integrated into the Honeywell/SPARTA TrackWise Digital platform.
editor's note: QUMAS has been absorbed into Honeywell's TrackWise Digital quality platform (also listed separately in this directory). If you're evaluating QUMAS, you're effectively evaluating TrackWise Digital.
QUMAS technology now lives inside Honeywell's TrackWise Digital platform — enterprise-only, heavily SI-dependent, and primarily relevant to large pharmaceutical manufacturers; SMB life sciences buyers have better options at accessible pricing.
AI score breakdown — 6 dimensions
SMB implementability 25%25
Enterprise-only. Mandatory SI (systems integrator) involvement. Implementations typically 12–24 months for pharma deployment. Not accessible for SMB life sciences companies.
Purpose fit 20%85
Enterprise pharma QMS depth: GxP document management, CAPA, training, audits, regulatory submissions, deviation management, and full validation support for FDA, EMA, and other regulatory bodies.
Tech modernity 20%68
Migrated into Honeywell's cloud platform. Modern cloud delivery but the underlying data model reflects legacy QUMAS/SPARTA architecture.
Documentation quality 15%65
Enterprise documentation available through Honeywell partner portal. Pre-sales evaluation through Honeywell account team.
Real user sentiment 10%58
Legacy QUMAS users have mixed reviews about transition to TrackWise. Enterprise pharma companies accept the complexity for regulatory requirements.
TCO transparency 10%22
No public pricing. Enterprise deal structure. Total cost of ownership is enterprise-scale — typically $500K+ including implementation services for a meaningful pharma deployment.
validate / explore this score:
Perplexity
ChatGPT
Claude
Google